Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.

Source:http://linkedlifedata.com/resource/pubmed/id/18006849

Cancer Res. 2007 Nov 15 67 22 11029-36

Download in:

View as

General Info

PMID
18006849